Hello and welcome to another episode of Sigma Nutrition Radio.

My name is Danny Lennon.

You are very welcome to the podcast. Today we're going to be

talking specifically about the potential impact of diet in the condition historically known as

polycystic ovary syndrome or PCOS, which has just now been renamed polyendocrine metabolic ovarian

syndrome, abbreviated PMM-O-S.

And this name change was set out just recently in a May 2026 publication that appeared in Lancet

Health Policy by Teed and colleagues.

This was following a multi-step global consensus process involving people with the condition,

health professionals, researchers, patient organizations, and professional societies across

various regions of the world. And the rationale for the change is that the old name is

inaccurate essentially and potentially misleading. So polycystic ovary syndrome implies that the

condition is defined by these pathological ovarian cysts. But that's not really what is going on

in this condition, as we will explain later in this episode. The ovarian feature, when it is present,

is better understood as arrested follicular development

or polycystic ovarian morphology rather than cysts in the usual pathological sense.

The old name also frames the condition too narrowly as a gynecological or an ovarian disorder,

but the syndrome is much broader than that. It involves

endocrine, metabolic, reproductive, dermatological, and psychological features. It can involve

things like irregular menstrual cycles, ovulatory dysfunction, elevated antigens, acne, impaired glucose regulation, insulin resistance,

fertility issues, and increased risks of higher rates of things like anxiety, depression,

body image distress, sleep problems, disorder eating. So a wide, multi-system condition that can

...